CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities

BiomElix® OnePositive
AI Analysis

Summary

BiomEdit acquired Folium Science's CRISPR-based precision microbiome technology and BiomElix® One, a poultry feed additive approved in Brazil, to expand its programmable veterinary biologics capabilities.

Outcome Details

BiomEdit acquired Folium Science's CRISPR-based precision microbiome technology and BiomElix® One pipeline assets

Importance:6/10
Sentiment:
0.60
acquisitionCRISPRmicrobiomeanimal healthveterinary biologicsBrazil approval
Related Companies

Read the original article

Published by PR Newswire Biotech on August 25, 2026 12:21 PM

Read Original